Search

everythinglearnresearchcommunity

for

Search:↓

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Infections during JAK inhibitor treatment for alopecia areata are usually manageable and rarely stop treatment permanently.

Ritlecitinib is a new treatment for severe hair loss in people 12 and older.

High kallistatin levels in diabetics worsen wound healing by blocking important cell signals.

Removing both KLK5 and KLK7 proteins can prevent death and skin issues in Netherton syndrome.

Baricitinib is not very effective for severe alopecia areata.

JAK inhibitors help hair regrowth but not fully effective for androgenetic alopecia.

MK-386 lowers DHT in blood and skin but not in semen.

Normal human melanocytes can avoid cell death through multiple pathways.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Inward rectifier potassium channels are important in many body functions and diseases, and could be potential drug targets.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

The peptide IMT-P8 can effectively deliver proteins into the skin and cells for potential skin treatments.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

SGK1 is important in cancer growth and treatment resistance, and targeting it could improve therapies.

miR-150 helps blood vessel cells develop and speeds up blood clot healing.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

OR-101 shows promise for treating alopecia areata by improving hair growth.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Targeted cancer therapies often cause serious skin problems that need careful management.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

Ritlecitinib can help about 14,000 people with severe hair loss.

Blocking DKK1 with siRNA can improve hair growth.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Irisin can promote hair growth by activating a specific signaling pathway.

Dermatologists are hesitant to prescribe Janus kinase inhibitors for alopecia areata due to safety concerns and lack of knowledge.

TGF-β inhibitors may help treat liver fibrosis by targeting various pathways.

3D imaging effectively tracks skin changes in vitiligo treatment.